|
|
ASCO 2012: Dr. Nooka - Survival outcomes of early autologous stem cell transplant (ASCT) followed by lenalidomide, bortezomib, and dexamethasone (RVD) maintenance in patients with high-risk multiple myeloma (MM)
Ajay Nooka, MD
Winship Cancer Center
Emory University
Atlanta, Georgia, USA
|
|
|
06.26.12 |
To view the video full screen, click on the small
 button next to the volume control in the
lower right hand corner.
|
 related articles
|
|
back
print